[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360320-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360320-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-cancer-signal-localization-in-mced-testing-minimizes-radiation-and-imaging-burden-compared-with-whole-body-imaging-approaches","Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches","","Efficient strategies are needed for diagnostic evaluation of multicancer early detection (MCED) tests to distinguish true-positive from apparent false-positive results. A previously published model was extended to compare two post–positive diagnostic strategies: a cancer signal origin (CSO)-guided approach with repeat MCED testing (CSO-retest) versus a whole-body imaging (WBI)-only approach using whole-body CT and PET/CT. The CSO-retest strategy reduced WBCT/PET/CT use 10- to 20-fold, while small decreases in specificity increased false positives and imaging needs. CSO-guided workups substantially lower estimated radiation exposure and unnecessary evaluations, with implications for MCED safety, cost, and accessibility.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-cancer-signal-localization-in-mced-testing-minimizes-radiation-and-imaging-burden-compared-with-whole-body-imaging-approaches/360320/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-cancer-signal-localization-in-mced-testing-minimizes-radiation-and-imaging-burden-compared-with-whole-body-imaging-approaches/360320.png","ImageObject",300,407,{"name":42,"@type":43},"Stanford","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in MCED diagnostic evaluation?","Question",{"text":63,"@type":64},"It addresses how to efficiently distinguish true-positive from apparent false-positive MCED test results while keeping diagnostic workups safe, accessible, and affordable.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do the two compared strategies differ?",{"text":68,"@type":64},"One strategy uses cancer signal origin (CSO) prediction with repeat MCED testing (CSO-retest), while the other relies on whole-body imaging (WBI-only) with whole-body CT followed by PET/CT.",{"name":70,"@type":61,"acceptedAnswer":71},"What impact does CSO-guided retesting have on radiation exposure?",{"text":72,"@type":64},"CSO-retest markedly reduces radiation exposure versus WBI-only, with initial evaluations for CSO-retest ranging from 0 to 26.1 mSv, while WBI-only carries an obligatory 28 mSv.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360320,1790187516,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},2336477552062,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches  \nMylynda Massart1, Sana Raoof2, Earl Hubbell3, and Eric A. Klein3  \n|  |  |  | A |  | B | S |  | T | R |  | A |  | C | T |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 􀀶 |  | Efficient strategies for diagnostic evaluation of multicancer early detection (MCED) tests are needed to distinguish true-positive from apparent false-positive (FP) test results. Extending a previously published model, we compared 2 post–positive MCED test diagnostic evaluation strategies: a cancer signal origin (CSO)–guided approach with repeat MCED testing to resolve FPs (CSOretest strategy) versus a whole-body imaging (WBI)–only strategy employing whole-body computed tomography (WBCT) followed by positron emission tomography (PET)/CT scans to resolve FPs. Analyses evaluated 2 scenarios with different test performance characteristics and specificities, with a number of imaging procedures required and radiation exposure for each strategy as outcomes measures. The CSO-retest strategy resulted in 10- to 20-fold reduction in the use of WBCT/PET/CT versus the WBI-only strategy across both scenarios. A 1% reduction in WBI-only test specificity from 99.5% to 98.5% led to a >3-fold increase in FPs and more than doubled WBI requirements. Estimated radiation exposure for initial diagnostic evaluations for the CSO-retest strategy were |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0 to 26.1 millisieverts (mSv), whereas all initial diagnostic evaluations for the WBI-only strategy carried an obligatory exposure of 28 mSv. For the 50% of CSO predictions requiring initial imaging, dose exposure ranged from 0.28 mSv (mammography) to 26.1 mSv (triple-phase renal CT), or 1% to 93% of the dose required for the WBI-only strategy. The results suggest that CSO-guided diagnostic strategies incorporating targeted workups and MCED retesting markedly reduce radiation exposure compared with a WBI-only approach, and small changes in MCED test specificity lead to significantly more unnecessary workups.\u003Cbr>Prevention Relevance: Using MCED tests with molecular CSO prediction and MCED retesting to resolve apparent FPs enables targeted evaluations via existing diagnostic pathways, reducing radiation exposure compared with MCED tests without this feature that rely on WBI. These findings have important implications for MCED implementation including safety, cost, and accessibility. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |\n\nIntroduction  \nBlood-based multicancer early detection (MCED) tests represent a novel approach to enhance cancer screening, broadening both the number and types of cancers that can be detected, and hold promise for improving both access and clinical outcomes. Multiple published reports document that MCED testing can be reliably implemented in a variety of clinical settings, including primary care (1), multistate health system","cbCaigc9VNrV40Wk","https://ap.wps.com/l/cbCaigc9VNrV40Wk","pdf",1395620,"English","# Introduction\n## Diagnostic evaluation challenge for MCED tests\n## CSO-guided strategy with repeat MCED testing\n## Whole-body imaging-only strategy","[{\"question\":\"What problem does the study address in MCED diagnostic evaluation?\",\"answer\":\"It addresses how to efficiently distinguish true-positive from apparent false-positive MCED test results while keeping diagnostic workups safe, accessible, and affordable.\"},{\"question\":\"How do the two compared strategies differ?\",\"answer\":\"One strategy uses cancer signal origin (CSO) prediction with repeat MCED testing (CSO-retest), while the other relies on whole-body imaging (WBI-only) with whole-body CT followed by PET/CT.\"},{\"question\":\"What impact does CSO-guided retesting have on radiation exposure?\",\"answer\":\"CSO-retest markedly reduces radiation exposure versus WBI-only, with initial evaluations for CSO-retest ranging from 0 to 26.1 mSv, while WBI-only carries an obligatory 28 mSv.\"}]","Molecular Cancer Signal Localization in MCED Testing Minimizes Radiation and Imaging Burden Compared with Whole-body Imaging Approaches | PDF",1790139594,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/890bd4e8d11fe44d2b1b9823ced8d08f.webp",983,1315,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44524462fc4a33c8d336451f94f019c3.webp",982,1314,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2b9b25dc4cd41fb36b3d5fc0c969c21f.webp",981,1312,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bd0b7d33fbfc30caf6369675bcd7883.webp",980,1311]